EXCALIARD PHARMACEUTICALS INC has a total of 46 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2009. It filed its patents most often in Japan, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ISLETONE AB, ARROWHEAD RES CORPORATION and TRANSIMMUNE AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 6 | |
#2 | Australia | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | United States | 4 | |
#5 | Republic of Korea | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | Brazil | 2 | |
#8 | Canada | 2 | |
#9 | China | 2 | |
#10 | Hong Kong | 2 | |
#11 | Mexico | 2 | |
#12 | New Zealand | 2 | |
#13 | Colombia | 1 | |
#14 | EAPO (Eurasian Patent Organization) | 1 | |
#15 | United Kingdom | 1 | |
#16 | Hungary | 1 | |
#17 | Israel | 1 | |
#18 | Singapore | 1 | |
#19 | Taiwan | 1 | |
#20 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Dean Nicholas M | 36 |
#2 | Foulkes J Gordon | 32 |
#3 | O'Donnell Niall | 29 |
#4 | Freier Susan M | 23 |
#5 | Bennett C Frank | 22 |
#6 | Jewell Mark | 10 |
#7 | Krochmal Lincoln | 10 |
#8 | Young Leroy | 10 |
#9 | Hardee Gregory | 10 |
#10 | Bennet Frank C | 4 |
Publication | Filing date | Title |
---|---|---|
TW201244724A | Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf) | |
EP2334319A1 | Method for reducing scarring during wound healing using antisense compounds directed to ctgf | |
CN107083386A | Prevent GEM 132 of CTGF and application thereof |